Long Curiosity· @Water46333865 · X·· 1 天前评分70
正文 · 原文
@Rakuten Medical #ESMO26
I like it that it postpones other new immune checkpoint options to a later line effectively leaving new options after relapse. Probably has very good abscopal effect in their treatment. May be combined with other later line chckpt inhibitors even.
47 浏览 · 0 赞 · 0 转发 · 1 回复
会议摘要
NCT06295731NCT06295731按 - **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC 对上
- **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
https://esmocongress.esmo.org帖内回复
- Long Curiosity@Water46333865
@Rakuten #ESMO26 #ESMO #HNSCC rakuten medical One caveat tho. A rather small N (19)
来源：Long Curiosity · x.com